In Memoriam: Richard Scolyer
Remembering the celebrated Australian pathologist who inspired new research into brain cancer treatment
-
By
-
Helen Bristow
-
June 8, 2026
-
Clinical Scorecard: In Memoriam: Richard Scolyer
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | |
| Care Setting | Oncology, research, and clinical trials |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Risks
- Consider potential side effects of immunotherapy, including autoimmune reactions.
Patient & Prescribing Data
Immunotherapy may improve survival rates, potentially matching those seen in melanoma treatments.
Clinical Best Practices
- Utilize large research databases and biospecimen banks for glioblastoma research.
- Encourage collaboration between pathologists and oncologists.
- Implement multidisciplinary approaches in treatment planning.
Related Resources & Content
